Will High-Dose Ifosfamide Become the Go-To Therapy in Recurrent Ewing Sarcoma?

(MedPage Today) -- CHICAGO--High-dose ifosfamide proved more effective at prolonging event-free survival (EFS) and overall survival (OS) than topotecan plus cyclophosphamide in relapsed/refractory Ewing sarcoma, according to the rEECur trial...